Clinical trial
Prospective Observational Study on the Natural History of Alpha-1 Antitrypsin Deficiency and Associated Liver Disease
NCT06512454 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Study on the Natural History of Alpha-1 Antitrypsin Deficiency and Associated Liver Disease
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 25, 2024
- Completion date
- December 31, 2031
- Enrollment
- 500 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
alpha1-antitrypsin deficiency